ScholarWorks@경상국립대학교

상세 보기

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon beta-1b

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

Hong, Sun In;
Ryu, Byung-Han;
Chong, Yong Pil;
Lee, Seungjun;
Kim, Sunjoo;
... Hong, Kyung-Wook;
... Bae, In-Gyu;
외 2명

Citations

WEB OF SCIENCE

11

Citations

SCOPUS

10

초록

[No abstract available]

키워드

Coronavirus; COVID-19; Hydroxychloroquine; Interferon; Lopinavir/ritonavir; SARS-CoV-2

제목: Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon beta-1b

제목 (타언어): Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

저자: Hong, Sun In; Ryu, Byung-Han; Chong, Yong Pil; Lee, Seungjun; Kim, Sunjoo; Kim, Ho Cheol; Hong, Kyung-Wook; Bae, In-Gyu; Cho, Oh-Hyun

DOI: 10.1016/j.ijantimicag.2020.106052

발행일: 2020-08

유형: Letter

저널명: International Journal of Antimicrobial Agents

권: 56

호: 2